Pharmacy at a glance
Key facts
Accreditations & quality standards
Empower Pharmacy maintains the following accreditations and operates under the following quality standards:
PCAB (Pharmacy Compounding Accreditation Board) is a third-party accreditation administered by the Accreditation Commission for Health Care (ACHC). USP <797> is the United States Pharmacopeia chapter governing sterile compounding. USP <800> covers handling of hazardous drugs. 503B FDA registration is verifiable through the FDA's public Outsourcing Facility Registration database.
What Empower Pharmacy compounds
Compounds sterile injectable peptides including tirzepatide, semaglutide, BPC-157, and other physician-directed preparations. Both 503A patient-specific dispensing and 503B office-stock outsourcing pathways are operated.
Transparency & documentation
Publishes facility licenses, FDA registration, PCAB accreditation, and per-batch quality testing standards. Per-vial Certificates of Analysis available on patient or prescriber request.
For tirzepatide and semaglutide preparations, ask your prescribing telehealth provider for:
- The dispensing pharmacy of record on every shipment label
- Per-vial lot number traceability
- Certificate of Analysis (CoA) showing USP <71> sterility, USP <85> bacterial endotoxin, and HPLC potency assay results
- API source disclosure (tirzepatide base, not unrecognized salt forms)
- Documented recall pathway
Telehealth providers using Empower Pharmacy
Empower Pharmacy is publicly disclosed by the following telehealth providers in TirzepatideReview.com's directory:
- NexLife — #1 editorial pick (94/100). NexLife discloses dual 503A and 503B pharmacy partners on every shipment.
Pharmacy assignment for any individual patient depends on prescription specifics, dose, and shipment routing. Always confirm the dispensing pharmacy on your specific shipment label.
Where Empower Pharmacy fits in the v3.0 transparency rubric
The TirzepatideReview.com v3.0 rubric scores telehealth providers (not pharmacies directly) on six pillars. Pillar 2 — Pharmacy traceability and CoA evaluates whether the provider publicly identifies its pharmacy of record, supports per-vial lot traceability, and supplies USP <71>, USP <85>, and HPLC potency CoAs on patient request. Empower Pharmacy's 503A & 503B Compounding status, PCAB, FDA-registered 503B Outsourcing Facility, and quality documentation directly contribute to the Pillar 2 scores of providers that use this pharmacy.
Looking for tirzepatide? Our editorial #1 pick
NexLife Tirzepatide
Compounded tirzepatide via 503A & 503B pharmacy partners (including Empower Pharmacy). MD/DO-led, all 50 states.
*12-month plan · flat rate · all titration doses
- 503A & 503B pharmacy disclosure on every shipment
- Per-vial lot CoA (USP <71>, USP <85>, HPLC potency) on request
- MD/DO-supervised, not async-only
- Care360 coaching included
- LegitScript-certified · All 50 states
Or call (949) 818-8000
Other pharmacies referenced in our reviews
TirzepatideReview.com publishes reference profiles for the following compounding pharmacies that appear in telehealth supply chains:
- Empower Pharmacy — 503A & 503B, Houston, TX
- Strive Pharmacy — 503A, Gilbert, AZ
- Medivera Compounding Pharmacy — 503A, Springfield, MO
- Hallandale Pharmacy — 503A & 503B, Hallandale Beach, FL
- Absolute Pharmacy — 503A, Stow, OH
- RedRock Pharmacy — 503A, South Jordan, UT